MAWAG
PCVX icon

Mid-American Wealth Advisory Group’s Vaxcyte PCVX Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,311
Closed -$270K – 234
2025
Q2 		$270K Buy
+8,311
New +$272K 0.13% 47

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Mid-American Wealth Advisory Group's PCVX Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of Vaxcyte (PCVX) in Q3 2025, closing a stake of 8,311 shares — an estimated $270K sold.

Mid-American Wealth Advisory Group first reported a position in PCVX in Q2 2025 and held it in 1 quarter. The position peaked at $270K in Q2 2025. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining Vaxcyte position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 8,311 Vaxcyte shares in Q3 2025, an estimated $270K.
  • Mid-American Wealth Advisory Group first reported a position in Vaxcyte in Q2 2025 and held it in 1 quarter.
  • Mid-American Wealth Advisory Group's Vaxcyte position peaked at $270K in Q2 2025.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.